MicroPort Scientific (FRA:MSK) Tariff Resilience Score: 4/10 (As of Jul. 04, 2026)


FRA:MSK MicroPort Scientific Corp FRA:MSK
40 GF Score
Price €0.74
GF Value €0.98
Valuation Modestly Undervalued
! 8 Warning Signs
View Full Analysis

What is MicroPort Scientific Tariff Resilience Score?

MicroPort Scientific FRA:MSK +7.30% 40 Tariff Resilience Score is 4 as of Jul. 04, 2026. GuruFocus rates FRA:MSK with a GF Score™ of 40/100 and a GF Value™ of €0.98 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 837 Medical Devices & Instruments companies, MicroPort Scientific ranks better than 70.01% on this metric.

MicroPort Scientific has the Tariff Resilience Score of 4, which implies that the company might have Average Resilient.

MicroPort Scientific has MicroPort is heavily reliant on global supply chains, with significant manufacturing in China and sales in the US and Europe. Previous tariffs have impacted costs, and while it has some alternative suppliers, its pricing power is limited. The medical device industry faces specific tariff vulnerabilities.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes MicroPort Scientific might have Average Resilient.

MicroPort Scientific  (FRA:MSK) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

MicroPort Scientific Tariff Resilience Score Related Terms

FRA:MSK vs ABT, SYK, MDT: Tariff Resilience Score Comparison

For the Medical Devices subindustry, MicroPort Scientific's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MicroPort Scientific Tariff Resilience Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, MicroPort Scientific's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where MicroPort Scientific's Tariff Resilience Score falls into.


FRA:MSK
40GF Score
MicroPort Scientific Corp FRA:MSK
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 4 mean?
MicroPort Scientific (FRA:MSK) has a Tariff Resilience Score of 4 as of Jul. 04, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, MicroPort Scientific ranks #251 out of 837 companies in the Medical Devices & Instruments industry, placing it in the top 30%.
Is MicroPort Scientific's Tariff Resilience Score too high?
MicroPort Scientific's current Tariff Resilience Score is 4. Based on the distribution chart, MicroPort Scientific ranks #251 out of 837 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, MicroPort Scientific has a GF Score™ of 40/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does MicroPort Scientific's Tariff Resilience Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, MicroPort Scientific ranks #251 out of 837 companies for Tariff Resilience Score. This puts MicroPort Scientific in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Medical Devices & Instruments company?
A good Tariff Resilience Score depends on the Medical Devices & Instruments industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. MicroPort Scientific's current Tariff Resilience Score is 4. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MicroPort Scientific stock overvalued right now?
Based on GuruFocus' analysis, MicroPort Scientific (FRA:MSK) is currently considered Modestly Undervalued. The stock's GF Value™ is €0.98, compared to a current price of €0.74 — trading 25% below its estimated fair value. The current Tariff Resilience Score is 4. MicroPort Scientific's overall GF Score™ is 40/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For MicroPort Scientific (FRA:MSK), the current Tariff Resilience Score is 4 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MicroPort Scientific (FRA:MSK) Overvalued in 2026?

Based on GuruFocus' analysis, MicroPort Scientific stock appears to be undervalued. The current stock price of €0.74 is trading 25% below its estimated GF Value™ of €0.98. GuruFocus considers MicroPort Scientific to be Modestly Undervalued.

Key valuation signals for FRA:MSK:

  • Tariff Resilience Score: 4
  • GF Value™: €0.98 vs. price of €0.74 (25% below fair value)
  • GF Score™: 40/100 with 8 warning signs

No single metric tells the full story. See the FRA:MSK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

MicroPort Scientific Business Description

Other Exchanges MCRPF:USA00853:Hong Kong
Address 1601 Zhangdong Road, Zhangjiang Hi-Tech Park, Shanghai, CHN, 201203
MicroPort Scientific Corp develops & markets medical devices in eight segments. Cardiovascular devices business: sales, manufacturing, & R&D of cardiovascular devices like drug-eluting stents. Orthopedics devices business: sales, manufacturing, R&D of orthopedics devices. CRM business: sales, manufacturing, R&D of cardiac rhythm management devices. Endovascular & peripheral vascular devices business: sales, manufacturing, R&D of endovascular & peripheral vascular devices. Neurovascular devices business: sales, manufacturing, R&D of neurovascular devices. Structural heart disease business: sales, manufacturing, R&D of heart valve devices. Surgical robot business: sales, manufacturing, & R&D of surgical robot devices. Surgical devices business: sales, manufacturing, R&D of surgical devices.
40GF Score

Get the complete analysis for FRA:MSK

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.74
Price
€0.98
GF Value